Growth Metrics

Novartis Ag (NVS) FCF Margin (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -3,755.00
Mar 31, 2023 -219,618.00
Dec 31, 2022 215,439.00
Sep 30, 2022 7,763.00
Jun 30, 2022 -8,399.00
Mar 31, 2022 8,401.00
Dec 31, 2021 -13,932.00
Sep 30, 2021 13,756.00
Jun 30, 2021 -6,979.00
Mar 31, 2021 -280,915.00
Dec 31, 2020 277,947.00
Sep 30, 2020 9,928.00
Jun 30, 2020 -8,121.00
Jun 30, 2019 -10,926.00
Mar 31, 2019 -7,474.00
Dec 31, 2018 7,905.00
Sep 30, 2018 10,063.00
Jun 30, 2018 -10,664.00
Mar 31, 2018 -19,414.00
Dec 31, 2017 11,688.00
Sep 30, 2017 -182,902.00
Dec 31, 2016 -23,568.00
Sep 30, 2016 -4,486.00
Jun 30, 2016 -20.37 Bn
Mar 31, 2016 20.37 Bn
Dec 31, 2015 -39,931,034.48 Bn
Mar 31, 2015 -64,136.00
Dec 31, 2014 23,574.00
Jun 30, 2009 2.94 Mn